Request Legal Help Now - Free

LAWSUITS NEWS & LEGAL INFORMATION

Proton Pump Inhibitor Legal News Articles & Interviews

View Lawyer Interviews only

Recent Studies Show Other Side Effects, including certain Cancers, with Long-term PPI Use

Recent Studies Show Other Side Effects, including certain Cancers, with Long-term PPI Use June 3, 2021. By Jane Mundy.
Santa Clara, CA For more than a decade, studies have shown that proton pump inhibitors (PPIs) are associated with serious side effects, including kidney failure and other injuries. Researchers now add to “other” injuries biliary track cancer, gallbladder cancer and cholecystitis (inflammation of the gallbladder) and might be carcinogenic.
Read [ Recent Studies Show Other Side Effects, including certain Cancers, with Long-term PPI Use ]

PPI Wrongful Death Lawsuit

PPI Wrongful Death Lawsuit April 16, 2021. By Jane Mundy.
Newark, NJ A wrongful death lawsuit has been filed against AstraZeneca, Merck & Co., Procter & Gamble and other manufacturers of proton pump inhibitor (PPI) drugs. Plaintiff Daisy Perez claims her husband, a New Mexico man, died of metastatic gastric cancer after taking Nexium and Prilosec.
Read [ PPI Wrongful Death Lawsuit ]

Proton Pump Inhibitor Maker Facing Wrongful Death Lawsuit

Proton Pump Inhibitor Maker Facing Wrongful Death Lawsuit February 18, 2021. By Jane Mundy.
Las Vegas, NV Proton Pump Inhibitor (PPI) manufacturers and distributors AstraZeneca and Merck are facing a wrongful death lawsuit alleging the side effects of Nexium caused stomach cancer, which lead to death.

Read [ Proton Pump Inhibitor Maker Facing Wrongful Death Lawsuit ]

Whittling Down PPI Cases for Bellwether Trials

Whittling Down PPI Cases for Bellwether Trials January 29, 2021. By Jane Mundy.
New Jersey  If all goes according to Judge Cecchi’s plan, the pool of Proton Pump Inhibitor drugs (PPI) cases will have whittled down to six only – from a total of 32 potential bellwether cases by the end of January.
Read [ Whittling Down PPI Cases for Bellwether Trials ]

Proton Pump Inhibitors – More Harm than Good, especially in COVID-19 Patients

Proton Pump Inhibitors – More Harm than Good, especially in COVID-19 Patients December 31, 2020. By Jane Mundy.
Santa Clara, CA Over the past several years, Proton Pump Inhibitors (PPI) have been linked to serious health complications. And more recent studies indicate that these acid reflux drugs do more harm than good. One such study opines that PPI exposure increases mortality in COVID-19 patients. Other studies suggest PPIs can damage major organs and regular use of PPI is linked to a higher risk of being diagnosed with type 2 diabetes and serious skin reactions such as life-threatening Stevens-Johnson Syndrome. And there is more…

Read [ Proton Pump Inhibitors – More Harm than Good, especially in COVID-19 Patients ]

“Acid Reflux Drugs Caused my Type 2 Diabetes”

“Acid Reflux Drugs Caused my Type 2 Diabetes” November 28, 2020. By Jane Mundy.
Phoenix, AZ Ten years ago Gary Phillips was diagnosed with type 2 diabetes. He had taken proton pump inhibitor (PPI) medications for acid reflux issues at least once a day for about 13 years but only knew that the medications were linked to diabetes when he read about PPI lawsuits. Unfortunately the meds worked— so he kept taking them. Now he takes insulin shots.
Read [ “Acid Reflux Drugs Caused my Type 2 Diabetes” ]

Regular Acid-reflux Drug Use Linked to Higher Risk of type 2 Diabetes

Regular Acid-reflux Drug Use Linked to Higher Risk of type 2 Diabetes October 25, 2020. By Jane Mundy.
Santa Clara, CA During this Pandemic there is also an epidemic that has been growing for decades and it is just as dangerous, perhaps even more so, than COVID 19. And drugs known as proton pump inhibitors or PPIs are feeding this epidemic: type 2 diabetes.
Read [ Regular Acid-reflux Drug Use Linked to Higher Risk of type 2 Diabetes ]

Study Further Links Proton Pump Inhibitors to Gastric Cancer and Conflicts with FDA study, Lawsuits to Follow

Study Further Links Proton Pump Inhibitors to Gastric Cancer and Conflicts with FDA study, Lawsuits to Follow May 31, 2018. By Jane Mundy.
Santa Clara, CA: A link between proton pump inhibitors (PPIs) and high risk of gastric cancer isn’t new, but the results of a new study conflicts with the FDA’s mandated PPI study.
Read [ Study Further Links Proton Pump Inhibitors to Gastric Cancer and Conflicts with FDA study, Lawsuits to Follow ]

Georgia Plaintiff Alleges Use of Nexium Caused Chronic Kidney Disease

Georgia Plaintiff Alleges Use of Nexium Caused Chronic Kidney Disease March 4, 2018. By Gordon Gibb.
Newark, NJ: Heartburn, more correctly known as acid reflux, continues to be a common complaint affecting a vast cross section of the American population. Relief is often in the form of medication - and, specifically proton pump inhibitors such as Nexium, a product of AstraZeneca. Plaintiff Shirlene Bonner began regular use of Nexium to relieve heartburn from 2003 until 2015, until a diagnosis of chronic kidney disease (CKD) found her searching for answers as to what may have triggered her CKD. Bonner alleges in her PPI lawsuit that Nexium, a proton pump inhibitor, is the root cause.
Read [ Georgia Plaintiff Alleges Use of Nexium Caused Chronic Kidney Disease ]

Childhood Asthma Risk Linked to Mother’s PPI Use during Pregnancy

Childhood Asthma Risk Linked to Mother’s PPI Use during Pregnancy February 5, 2018. By Anne Wallace.
Washington, DC: As many as 80 percent of expectant mothers suffer from heartburn or acid indigestion during pregnancy. Until recently proton pump inhibitors (PPIs), such as Nexium, Prilosec and Prevacid, were thought to be both effective for mom and safe for baby.
Read [ Childhood Asthma Risk Linked to Mother’s PPI Use during Pregnancy ]

Page: 1  2     Next»

Request Legal Help Now! - Free